Lucas Research

Moorehead City, North Carolina 28557

0 studies enrolling now · 1 studies all time

What they study most

Non-Alcoholic Fatty Liver Disease

Studies at this site

• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — Running, not enrolling